Depressive Symptoms, Exercise, and Brain-Derived Neurotrophic Factor in Fibromyalgia Syndrome: A Mini Review
DOI:
https://doi.org/10.12970/2310-9874.2013.01.01.4Keywords:
Fibromyalgia syndrome depression, exercise, bdnf.Abstract
Fibromyalgia syndrome is a chronic widespread pain condition. Other symptoms often can be found, such as fatigue, lack of sleep, irritable bowel syndrome, and mood disturbance. In addition, depression is a clinically relevant symptom that commonly found in fibromyalgia syndrome patients. Brain-derived neurotrophic factor has been known to play a role in fibromyalgia syndrome patients. Additionally, brain derived neurotrophic factor is related to depression. However, the role of this neurotrophin and depression in fibromyalgia syndrome patients needs to be elucidated. Exercise is one of recommended treatment modalities for fibromyalgia syndrome patients which may influence the level of brain-derived neurotrophic factor. Thus, this review summarize the available data on the correlation of brain-derived neurotrophic factor with depression in fibromyalgia syndrome patients and the knowledge about influences of exercise on brain-derived neurotrophic factor levels.
References
Carville SF, Arendt-Nielsen S, Bliddal H, et al. EULAR evidence-based recommendations for the management of fibromyalgia syndrome. Ann Rheum Dis 2008; 67(4): 536-41. http://dx.doi.org/10.1136/ard.2007.071522
Mas AJ, Carmona L, Valverde M, Ribas B. Prevalence and impact of fibromyalgia on function and quality of life in individuals from the general population: results from a nationwide study in Spain. Clin Exp Rheumatol 2008; 26: 519-26.
Branco JC, Bannwarth B, Failde I, et al. Prevalence of fibromyalgia: a survey in five European countries. Semin Arthrit Rheumat 2010; 39(6): 448-53. http://dx.doi.org/10.1016/j.semarthrit.2008.12.003
Wolfe F, Ross K, Anderson J, et al. The prevalence and characteristics of fibromyalgia in the general population. Arhtrit Rheum 1995; 38: 19-28. http://dx.doi.org/10.1002/art.1780380104
Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthrit Rheum 1990; 33(2): 160-72. http://dx.doi.org/10.1002/art.1780330203
Wolfe F, Clauw DJ, Fitzcharles MA, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthrit Care Res 2010; 62(5): 600-10. http://dx.doi.org/10.1002/acr.20140
Pellegrino MJ, Waylonis GW, Sommer A. Familial occurrence of primary “bromyalgia. Arch Phys Med Rehabilit 1989; 70: 61-63.
Stormorken H, Brosstad F. Fibromyalgia: Family clustering and sensory urgency with early onset indicate genetic predisposition and thus true disease. Scandin J Rheumatol 1992; 21: 207. http://dx.doi.org/10.3109/03009749209099225
Offenbaecher M, Bondy B, de Jonge S, et al. Possible association of fibromyalgia with a polymorphism in the serotonin transporter gene regulatory region. Arthrit Rheum 1999; 42(11): 2482-88. http://dx.doi.org/10.1002/1529- 0131(199911)42:113.0.CO;2-B
Crofford L, Pillemer S, Kalogeras K, et al. Hypothalamic± pituitary±adrenal axis perturbations in patients with “bromyalgia. Arthrit Rheum 1994; 37: 1583-92. http://dx.doi.org/10.1002/art.1780371105
Ahles TA, Khan SA, Yunus MB, Spiegel DA, Masi AT. Psychiatric status of patients with primary fibromyalgia, patients with rheumatoid arthritis and subjects without pain: A blind compariosn of DSM-III diagnoses. Am J Psychiatry 1991; 148: 1721-6.
Kurland JE, Coyle WJ, Winkler A, Zable E. Prevalence of irritable bowel syndrome and depression in fibromyalgia. Dig Dis Sci 2006; 51: 454-60. http://dx.doi.org/10.1007/s10620-006-3154-7
Epstein SA, Kay G, Clauw D, et al. Psychiatric disorders in patients with fibromyalgia. A multicenter investigation. Psychosomatics 1999; 40: 57-63. http://dx.doi.org/10.1016/S0033-3182(99)71272-7
Johnson M, Paananen ML, Rahinantti P, Hannonen P. Depressed fibromyalgia patients are equipped with an emphatic competence dependent self-esteem. Clin Rheumatol 1997; 16: 578-84. http://dx.doi.org/10.1007/BF02247798
Offenbächer M, Glatzeder K, Ackenheil M. Self-reported depression, familial history of depression and fibromyalgia(FM), and psychological distress in patients with F M. Zeitschrift für Rheumatol 1998; 57(Suppl. 2): 94-96. http://dx.doi.org/10.1007/s003930050245
Tot S, Sahin G, Oral T, Verimli A. Primary fibromyalgia and depression: The role of relatives in fibromyalgia. Pain Clin 2004; 16(3): 261-26. http://dx.doi.org/10.1163/1568569041798380
Kurtze N, Gundersen K, Svebak S. Quality of life, functional disability and lifestyle among subgroups of fibromyalgia patients: the significance of anxiety and depression. Br J Med Psychol 1999; 72: 471-84. http://dx.doi.org/10.1348/000711299160185
Finset A, Wigers S, Götestam KG. Depressed mood impedes pain treatment response in patients with fibromyalgia. J Rheumatol 2004; 31: 976-80.
Walker EA, Keegan D, Gardner G, Sullivan M, Katon WJ, Bernstein D. Psychosocial factors in fibromyalgia compared with rheumatoid arthritis: I. Psychiatric diagnoses and functional disability. Psychosom Med 1997; 59: 565-71.
Franks H, Cronan T, Oliver K. Social support in women with fibromyalgia: is quality more important than quantity? J Commun Psychol 2004; 32: 425-38. http://dx.doi.org/10.1002/jcop.20011
Fuller-Thomson E, Nimigon-Young J, Brennenstuhl S. Individuals with fibromyalgia and depression: Findings from a nationally representative. Can Survey Rheumatol Int 2012; 32(4): 853-62.
Fietta P, Fietta P, Paolo Manganelli: Fibromyalgia and psychiatric disorders. Acta Biomed 2007; 78: 88-95.
Nugraha B, Korallus C, Gutenbrunner C. Serum level of brain-derived neurotrophic factor in fibromyalgia syndrome correlates with depression but not anxiety. Neurochem Int 2013; 62(3): 281-86. http://dx.doi.org/10.1016/j.neuint.2013.01.001
Van Liew C, Brown KC, Cronan TA, Bigatti SM, Kothari DJ. Predictors of pain and functioning over time in fibromyalgia syndrome: an autoregressive path analysis. Arthrit Care Res (Hoboken) 2013; 65(2): 251-56. http://dx.doi.org/10.1002/acr.21792
Santoro MS, Cronan TA. Depression, self-efficacy, health status, and health care costs: A comparison of men with fibromyalgia or osteoarthritis. J Musculoskeletal Pain 2013; 21(2): 126-34. http://dx.doi.org/10.3109/10582452.2013.795639
Haas L, Portela LV, Bohmer AE, Oses JP, Lara DR. Increased plasma levels of brain derived neurotrophic factor (BDNF) in patients with fibromyalgia. Neurochem Res 2010; 35(5): 830-34. http://dx.doi.org/10.1007/s11064-010-0129-z
Laske C, Stransky E, Eschweiler GW, et al. Increased BDNF serum concentration in fibromyalgia with or without depression or antidepressants. J Psy Res 2007; 41(7): 600- 605. http://dx.doi.org/10.1016/j.jpsychires.2006.02.007
Sarchielli P, Mancini ML, Floridi A, et al. Increased levels of neurotrophins are not specific for chronic migraine: evidence from primary fibromyalgia syndrome. The Journal of Pain: Official Journal of the American Pain Society 2007; 8(9): 737- 45. http://dx.doi.org/10.1016/j.jpain.2007.05.002
Nugraha B, Karst M, Engeli S, Gutenbrunner C. Brain derived neurotrophic factor and exercise in fibromyalgia syndrome patients: a mini review. Rheumatol Int 2012; 32(9): 2593-99. http://dx.doi.org/10.1007/s00296-011-2348-2
http: //www.who.int/topics/depression/en/ (accessed 14 October 2013).
Malberg JE, Blendy JA. Antidepressant action: to the nucleus and beyond. Trends Pharmacol Sci 2005; 26(12): 631-38. http://dx.doi.org/10.1016/j.tips.2005.10.005
Thoenen H. Neurotrophins and neuronal plasticity. Science 1995; 270: 593-98. http://dx.doi.org/10.1126/science.270.5236.593
Lu P, Jones LL, Tuszynski MH. BDNF-expressing marrow stromal cells support extensive axonal growth at sites of spinal cord injury. Exper Neurol 2005; 191(2): 344-60. http://dx.doi.org/10.1016/j.expneurol.2004.09.018
Deppmann CD, Mihalas S, Sharma N, Lonze BE, Niebur E, Ginty DD. A model for neuronal competition during development. Science 2008; 320(5874): 369-73. http://dx.doi.org/10.1126/science.1152677
Karege F, Perret G, Bondolfi G, Schwald M, Bertschy G, Aubry JM. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res 2002; 109(2): 143-48. http://dx.doi.org/10.1016/S0165-1781(02)00005-7
Lommatzsch M, Zingler D, Schuhbaeck K, et al. The impact of age, weight and gender on BDNF levels in human platelets and plasma. Neurobiol Aging 2005; 26(1): 115-23. http://dx.doi.org/10.1016/j.neurobiolaging.2004.03.002
Cunha A, Frey BN, Andreazza AC, et al. Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes. Neurosci Lett 2006; 398(3): 215-19. http://dx.doi.org/10.1016/j.neulet.2005.12.085
Palomino A, Vallejo-Illarramendi A, González-Pinto A, et al. Decreased levels of plasma BDNF in first-episode schizophrenia and bipolar disorder patients. Schizophrenia Res 2006; 86(1): 321-22. http://dx.doi.org/10.1016/j.schres.2006.05.028
Coppell AL, Pei Q, Zetterström TSC. Bi-phasic change in BDNF gene expression following antidepressant drug treatment. Neuropharmacology 2003; 44(7): 903-10. http://dx.doi.org/10.1016/S0028-3908(03)00077-7
De Foubert G, Carney SL, Robinson CS. et al. Fluoxetine induced change in rat brain expression of brain-derived neurotrophic factor varies depending on length of treatment. Neuroscience 2004; 128(3): 597-604. http://dx.doi.org/10.1016/j.neuroscience.2004.06.054
Altieri M, Marini F, Arban R, Vitulli G, Jansson BO. Expression analysis of brain-derived neurotrophic factor (BDNF) mRNA isoforms after chronic and acute antidepressant treatment. Brain Res 2004; 1000(1): 148-55. http://dx.doi.org/10.1016/j.brainres.2003.12.028
Monteleone P, Serritella C, Martiadis V, Maj M. Decreased levels of serum brain derived neurotrophic factor in both depressed and euthymic patients with unipolar depression and in euthymic patients with bipolar I and II disorders. Bipolar Disorders 2008; 10(1): 95-100. http://dx.doi.org/10.1111/j.1399-5618.2008.00459.x
Sen S, Duman R, Sanacora G. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol Psychiatry 2008; 64(6): 527-32. http://dx.doi.org/10.1016/j.biopsych.2008.05.005
Yu H, Chen ZY. The role of BDNF in depression on the basis of its location in the neural circuitry. Acta Pharmacol Sinica 2010; 32(1): 3-11. http://dx.doi.org/10.1038/aps.2010.184
Molendijk ML, Bus BA, Spinhoven P, et al. Serum levels of brain-derived neurotrophic factor in major depressive disorder: state-trait issues, clinical features and pharmacological treatment. Mol Psychiatry 2011; 16(11): 1088-95. http://dx.doi.org/10.1038/mp.2010.98
Kononen J, Soinila S, Persson H, Honkaniemi J, Hökfelt T, Pelto-Huikko M. Neurotrophins and their receptors in the rat pituitary gland: regulation of BDNF and trkB mRNA levels by adrenal hormones. Brain Res Mol Brain Res 1994; 27: 347- 54. http://dx.doi.org/10.1016/0169-328X(94)90022-1
Tsukinoki K, Saruta J, Muto N, Sasaguri K, Sato S, Tan-Ishii N, Watanabe Y. Submandibular glands contribute to increases in plasma BDNF levels. J Dental Res 2007; 86(3): 260-64. http://dx.doi.org/10.1177/154405910708600312
Pizzorusso T, Ratto GM, Putignano E, Maffei L. Brain derived neurotrophic factor causes cAMP response element binding protein phosphorylation in absence of calcium increases in slices and cultured neurons from rat visual cortex. J Neurosci 2000; 20: 2809-16.
Rodgers EE, Theibert AB. Functions of PI 3-kinase in development of the nervous system. Int J Dev Neuro 2002; 20(3): 187-97. http://dx.doi.org/10.1016/S0736-5748(02)00047-3
Fang ZH, Lee CH, Seo MK, et al. Effect of treadmill exercise on the BDNF-mediated pathway in the hippocampus of stressed rats. Neurosci Res 2013; 76(4): 187-94. http://dx.doi.org/10.1016/j.neures.2013.04.005
Kaidanovich-Beilin O, Milman A, Weizman A, Pick CG, Eldar Finkelman H. Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on - catenin in mouse hippocampus. Biol Psychiatry 2004; 55(8): 781-84. http://dx.doi.org/10.1016/j.biopsych.2004.01.008
Rosa AO, Kaster MP, Binfaré RW, et al. Antidepressant-like effect of the novel thiadiazolidinone NP031115 in mice. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32(6): 1549- 56. http://dx.doi.org/10.1016/j.pnpbp.2008.05.020
Dunn AL, Trivedi MH, Kampert JB, Clark CG, Chambliss HO. Exercise treatment for depression: efficacy and dose response. Am J Prevent Med 2005; 28(1): 1-8. http://dx.doi.org/10.1016/j.amepre.2004.09.003
Knapen J, Sommerijns E, Vancampfort D, et al. State anxiety and subjective well-being responses to acute bouts of aerobic exercise in patients with depressive and anxiety disorders. Br J Sports Med 2009; 43(10): 756-59. http://dx.doi.org/10.1136/bjsm.2008.052654
Stanton R, Reaburn P. Exercise and the treatment of depression: A review of the exercise program variables. J Sci Med Sport 2013; PII: S1440-2440(13)00058-3.
Busch AJ, Webber SC, Brachaniec M, et al. Exercise therapy for fibromyalgia. Curr Pain Headache Reports 2011; 15(5): 358-67. http://dx.doi.org/10.1007/s11916-011-0214-2
Häuser W, Klose P, Langhorst J, Moradi B, et al. Research article Efficacy of different types of aerobic exercise in fibromyalgia syndrome: a systematic review and meta analysis of randomised controlled trials. Arthrit Res Therapy 2010; 12: R79. http://dx.doi.org/10.1186/ar3002
Merighi A, Salio C, Ghirri A, et al. BDNF as a pain modulator. Prog Neurobiol 2008; 85(3): 297-17. http://dx.doi.org/10.1016/j.pneurobio.2008.04.004
Neeper SA, Gomezpinilla F, Choi J, Cotman C. Exercise and brain neurotrophins. Nature 1995; 373(6510): 109. http://dx.doi.org/10.1038/373109a0
Griesbach GS, Hovda DA, Gomez-Pinilla F. Exercise induced improvement in cognitive performance after traumatic brain injury in rats is dependent on BDNF activation. Brain Res 2009; 1288: 105-15. http://dx.doi.org/10.1016/j.brainres.2009.06.045
